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A detailed mathematical model predicts serial engagement of
IgE-FcεRI complexes can enhance Syk activation in mast cells1
Ambarish Nag*,†, Michael I. Monine*, Michael L. Blinov‡, and Byron Goldstein*,§
*Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM
87545, USA
‡Center for Cell Analysis and Modeling, University of Connecticut Health Center, 263 Farmington
Avenue, Farmington, CT 06032-1507
Abstract
The term serial engagement was introduced to describe the ability of a single peptide, bound to a
major histocompatibility complex molecule, to sequentially interact with T cell receptors within
the contact region between a T cell and an antigen-presenting cell. In addition to ligands on
surfaces, soluble multivalent ligands can serially engage cell surface receptors with sites on the
ligand binding and dissociating from receptors many times before all ligand sites become free and
the ligand leaves the surface. To evaluate the role of serial engagement in Syk activation we use a
detailed mathematical model of the initial signaling cascade that is triggered when FcεRI is
aggregated on mast cells by multivalent antigens. Although serial engagement is not required for
mast cell signaling, it can influence the recruitment of Syk to the receptor and subsequent Syk
phosphorylation. Simulating the response of mast cells to ligands that serially engage receptors at
different rates shows that increasing the rate of serial engagement by increasing the rate of
dissociation of the ligand-receptor bond decreases Syk phosphorylation. Increasing serial
engagement by increasing the rate at which receptors are cross-linked, for example by increasing
the forward rate constant for cross-linking or increasing the valence of the ligand, increases Syk
phosphorylation. When serial engagement enhances Syk phosphorylation it does so by partially
reversing the effects of kinetic proofreading. Serial engagement rapidly returns receptors that have
dissociated from aggregates to new aggregates before the receptors have fully returned to their
basal state.
Introduction
The terms serial triggering and serial engagement entered the immunological lexicon when
Valitutti et al. [1, 2] reported that within the contact area between an antigen presenting cell
(APC) and a T cell, a few antigenic peptides bound to major histocompatibility complex
molecules (pMHC) mediated the internalization of hundreds of T cell receptors (TCRs). Itoh
et al. [3] confirmed this result and showed that equating a pMHC engagement with an
internalized TCR under-counted the number of serial engagements. They observed that TCR
internalization closely followed the extent of ζ chain phosphorylation. Thus, pMHC-TCR
engagements that resulted in partial ζ chain phosphorylation, but not TCR internalization,
were not counted.
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The observation that TCRs undergo serial engagement, coupled with the kinetic
proofreading model for cell signaling [4, 5], led to the prediction that for T cell activation
there should be an optimal range of half-lives for the pMHC-TCR bond [6]. The basic idea
of kinetic proofreading is that for a TCR to become activated it must remain bound to a
pMHC long enough for a set of biochemical modifications to occur. If the pMHC dissociates
from the TCR before the necessary modifications have been completed, signaling is
frustrated and activation is not achieved. For a T-cell to produce a measurable response,
multiple TCRs must be activated. Therefore, at low pMHC density, a single pMHC must
trigger many TCR before it diffuses out of the contact region. If the pMHC dissociates too
rapidly, it will encounter many TCRs but activate few while if it remains bound too long it
will activate those it encounters but encounters will be rare. The recognition that the pMHC-
TCR bond half-life has opposite effects on kinetic proofreading and serial engagement led to
the proposal that to achieve an optimal rate of TCR activation there should be an optimal
half-life, or equivalently an optimal dissociation rate constant koff, [6, 7]. Although some
studies have found an optimal half-life for T cell activation [8, 9, 10], there are other results
that are inconsistent with this model (reviewed in [11, 12]). For example, TCRs have been
engineered with high affinity TCR-pMHC interactions and long half-lives so that their
cognate peptides undergo little serial engagement, yet these TCRs were efficiently
stimulated by these peptides [13, 14].
Although there has been a considerable effort to unravel the role of serial engagement of
TCRs in activating T-cells, the role of serial engagement of other multichain immune
recognition receptors in cell activation has received little attention. This is perhaps
surprising, since avidity, often a manifestation of serial engagement and a property of
soluble multivalent ligands, was introduced in immunology more than fifty years ago to
distinguish between the binding properties of an antibody and its monovalent Fab fragment
(reviewed in [15]). It was observed that an IgG, at low concentrations, could bind to a
surface containing multiple binding sites (epitopes) with an apparent affinity that was orders
of magnitude greater than the equilibrium constant for binding of one of its Fab sites to an
epitope [16, 17, 18]. Avidity arises when the density of surface binding sites is sufficiently
high that multivalent ligands are observed to dissociate from the surface more slowly than
their monovalent counter parts, thus exhibiting a high apparent affinity. When a site on a
doubly bound IgG dissociates, the epitope it was bound to will diffuse away. If this newly
freed site on the IgG binds to another epitope before its second site dissociates, the IgG will
remain bound to the surface. Thus, avidity can arise by ligands serially engaging epitopes,
“walking” along the surface from epitope to epitope.
Avidity can arise in a second way that does not require serial engagement. For example,
cross-linking IgE-FcεRI complexes on rat basophilic leukemia (RBL) cells with a highly
multivalent antigen leads to the rapid formation of large stable aggregates of immobilized
receptors [19, 20]. This raises the possibility that a site on a bound ligand can dissociate
from, and rebind to, the same immobilized receptor many times, effectively increasing its
off rate constant, before all its sites on the ligand become free and the ligand dissociates
from the cell. Recent multi-color tracking experiments show that small aggregates of IgE-
FcεRI complexes, made up of two to four receptors, remain mobile on the RBL surface even
at doses that result in degranulation [21].
A major difficulty in assessing the role of serial engagement of receptors in cell signaling is
that the phenomena cannot be studied in isolation. As we will discuss, increasing the
ligand’s forward cross-linking rate constant, its reverse rate constant or its valence will
increase the rate at which the ligand serial engages receptors, but each of these
manipulations will effect receptor activation in different ways. To assess the role of serial
engagement in mast cell signaling, we use a detailed mathematical model of the early events
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triggered when IgE-FcεRI complexes are exposed to a bivalent or trivalent ligand on RBL
cells [22]. Using this model will allow us to delineate how different alterations in the
binding properties of the ligand, that result in the same rates of serial engagement of
receptors, can alter receptor activation in different ways.
Mast cell responses mediated by FcεRI are initiated when a multivalent ligand, an allergen
for example, aggregates the receptors. Maintenance of the response does not require that
new aggregates constantly form. Kent et al. [23] exposed RBL cells briefly to covalently
cross-linked oligomers of IgE and then added excess monomeric IgE to prevent further
aggregation of receptors. Under these conditions, aggregated receptors continued to signal.
Phosphorylation of the β and γ immunoreceptor tyrosine-based activating motifs (ITAMs),
phosphorylation of the protein tyrosine kinase Syk, and the release of histamine containing
granules were sustained for substantial lengths of time after new aggregate formation was
blocked. Although serial engagement of IgE-FcεRI complexes is not necessary for mast cell
signaling, there remains the question, can serial engagement enhance mast cell response at
low allergen concentrations? After deriving an expression for the rate at which a ligand of
valence N serially engages receptors on a surface, we will refine this question and then use
the model of Faeder et al. [22] to answer it.
Materials and Methods
Bivalent ligands
We use the model of Faeder et al. [22] to simulate the early response of RBL cells to the
addition of a reversible bivalent ligand that binds to, and dimerizes, IgE-Fc complexes on
RBL cell surfaces. The model consists of a network of 354 distinct chemical species
connected by 3680 chemical reactions, 21 rate constants and three concentrations, the
surface concentrations of FcεRI and available Lyn, and the total concentration of Syk. With
the exception of the rate constants that describe the interaction of the bivalent ligand with
IgE, k+1, k−1, k+2 and k−2, the parameters used in the simulations are the same as those given
in Table I of reference [22]. In the simulations we take koff = k−1 = k−2. A major
simplification of the model is that multiple tyrosines on receptor subunits and Syk are
lumped into single units so that for example, ITAMs are either phosphorylated or not
phosphorylated. The concentrations of Lyn, Syk and FcεRI are specific for RBL cells. The
interactions among the components of the model (the reaction rules) were specified in the
syntax of the second-generation version of BioNetGen, which automatically generates the
set of ODEs that describe the network [24, 25]. The open-source software
(http://bionetgen.org) uses standard numerical methods to solve the set of ODEs and obtain
the time courses for the 354 chemical species. The outputs are the weighted sums of the
appropriate chemical species. For example, activated Syk is the sum of those chemical
species that have a single Syk phosphorylated by a Syk and bound to a γ ITAM plus two
times the sum of those chemical species that are receptor dimers and contain two such Syk
molecules.
Trivalent ligands
We generalize the model of Faeder et al. [22] to simulate the early signaling events triggered
by the addition of a symmetric trivalent ligand with three identical binding sites interacting
with IgE bound to FcεRI on RBL cells. There is now an additional surface cross-linking
reaction involving a trivalent ligand with two of its sites bound cross-linking a third IgE-
FcεRI describe by rate constants k−3 and k+3. In the simulations, we take koff = k−1 = k−2 =
k−3 and k+2 = k+3. It is assumed that a Lyn bound to a receptor can randomly
transphosphorylate any other receptor in the aggregate with the same rates, as it was
assumed for the dimeric aggregate. To go from a dimer with two identical binding sites to a
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trimer with three identical binding sites requires only changing one rule in the BioNetGen
file, the rule that defines the stoichiometry of the ligand and its binding from solution to a
receptor on the cell surface. In the model, kinases act on all substrates in their vicinity. The
kinase activity in an aggregate is summed so, for example, if three Syk molecules are in an
aggregate, the rate of phosphorylation of a Syk by the two adjacent Syk is twice the rate of
phosphorylation as when only two Syk molecules are in the aggregate. The BioNetGen files
for the dimer and trimer are given in the Supplementary Information. For the trivalent ligand
the model expands to 2954 distinct chemical species connected by 49948 reactions.
Results
First, we obtain an expression for the rate of serial engagement of a multivalent ligand of
valence N binding to free mobile receptors on a cell surface that has a concentration of R
free receptors. This expression allows us to choose parameter values that define ligands with
different rates of serial engagement. We then use these parameter values to simulate the
early response of mast cells to ligands that serial engage receptors at different rates. We use
as our measure of signaling response, receptors that have fully activated Syk associated with
their γ ITAMs. Syk becomes partially active upon binding through its two SH2 domains to
the doubly phosphorylated γ ITAM [26]. In our model, Syk is partially active when bound to
the γ ITAM and fully active when it has been transphosphorylated on its activation loop
tyrosines by a second Syk (reviewed in [22]). Finally, we use the results of the simulations
to evaluate the role of serial engagement in early responses of mast cell signaling.
Serial engagement of a N-valent ligand
The rate of serial engagement equals the number of receptors the ligand encounters from the
time ta it forms its first attachment to a cell surface receptor until the time tb its last bond
breaks, divided by the time this process lasted, tb — ta. Figure 1 illustrates the reactions a
pentavalent ligand can undergo once it is initially bound to a receptor on a surface.
The mean time an N-valent ligand, that initially has one site bound to a receptor, remains on
a surface, when the concentration of free receptors is R, is [27, 28]
(1)
where K2 = k+2 /koff is the equilibrium cross-linking constant.
In the Appendix we derive the following expression for nN, the mean number of receptors an
N-valent ligand that initially has one site bound to a receptor serial engages before it
dissociates from the cell surface.
(2)
The average rate, rN, an N-valent ligand serially engages receptors is
(3)
In Table I we evaluate these expressions for N = 1,2,3,4,5 and K2R = 0.10, 1.0 and 10.0. The
parameter K2R is the product of the surface equilibrium cross-linking constant and the
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surface concentration of free receptors. Larger values of K2R favor aggregate formation.
Note that for large values of K2R, as the valence is increased, the number of serial
engagements and the mean time the ligand remains bound to the cell rises rapidly but their
ratio, the rate of serial engagement, increases only modestly. From Eq (1)–Eq (3), it can be
shown that the maximal rate of serial engagement achievable by an N- valent ligand when
koff is fixed and k+2R is increased is Nkoff. When k+2R is fixed and koff is increased the
maximal rate is k+2R.
The rates of serial engagement of receptors for bivalent and trivalent ligands
We now focus on bivalent and trivalent ligands interacting with monovalent receptors. From
Eq. (1) – Eq. (3), we have that the rate of serial engagement of a bivalent ligand
(4)
A second way this result can be obtained is to note that one receptor is bound and released
by a bivalent ligand in one cycle time tc so that r2 = 1/tc. The cycle time is the sum of the
mean times for a site on a doubly bound ligand to open and for the singly bound ligand to
bind to another receptor, i.e., tc = 1/(2koff) + 1/(k+2R). (When the ligand is a pMHC rather
than a bivalent ligand the factor of two on the right hand side of Eq. (4) becomes a one [29].)
This simple approach for calculating r2 cannot easily be generalized to ligands with valence
greater than two because for these ligands there is more than one recycling time.
From Eq. (1) – Eq. (3), we obtain the following expression for the rate of serial engagement
of trivalent ligand
(5)
It is easy to see from these expressions that for large values of K2R, the rate of serial
engagement approaches its maximal value of Nkoff. We use Eq. (4) and Eq. (5) to pick the
parameter values that characterize the ligands for our simulations.
There are three separate ways to vary the properties of a ligand to enhance serial
engagement, increase koff, increase k+2 or increase the valence of the ligand:
1. Increasing koff increases the rate at which the ligand serial engages receptors but
this has the deleterious effect of enhancing kinetic proofreading by reducing the
time a receptor remains in an aggregate. Once a receptor leaves an aggregate,
unless it can rapidly enter into a new aggregate, all modifications it has undergone
will be reversed and it will return to its basal state [30, 31].
2. Increasing k+2 reduces the time it takes a free site on a ligand in a ligand-receptor
complex to bind to a new receptor. This enhances the effects of serial engagement
by making it more likely that a ligand-receptor complex will form a new dimer
before the ligand dissociates and the receptor returns to its basal state.
3. Increasing the valence of the ligand has a similar effect to increasing the forward
rate constant. For an N-valent ligand bound through a single site to a receptor, the
forward rate of binding a second receptor and forming a dimer is proportional to (N
− 1)k+2. However, increasing the valence introduces other effects as well. A higher
valent ligand can form larger aggregates and large aggregates are more effective at
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signaling than smaller aggregates, even when the ligands are oligomers of IgE that
do not undergo serial engagement [32]. In RBL cells, Lyn, the kinase that is
responsible for ITAM phosphorylation, is limiting [33, 34]. Therefore, larger
aggregates have a higher probability than receptor dimers of containing a receptor
associated with Lyn, and a Lyn in an aggregate can serial phosphorylate all its
neighboring receptors in the aggregate.
Simulations of mast cell responses to bivalent and trivalent ligands for different rates of
serial engagement
We use the model of Faeder et al. [22] to assess the role of serial engagement in mast cell
signaling (see Methods). The predicted outputs of the model that we use in our study are the
concentrations (number per cell) of the phosphorylated β and γ ITAMs of FcεRI, and the
concentration of Syk bound to a phosphorylated γ ITAM and transphosphorylated on its
activation loop tyrosines by a Syk bound to an adjacent receptor. We refer to Syk bound to
the γ ITAM and phosphorylated on its activation loop tyrosines as fully activated Syk or
phosphorylated Syk. Using antibodies specific for phosphorylated tyrosines in the activation
loop of Syk, it has been shown that upon FcεRI aggregation, these tyrosines became
phosphorylated and this phosphorylation depended on the kinase activity of Syk [35]. The
presence of these activation loop tyrosines are necessary for Syk-mediated propagation of
FcεRI signaling [36].
Increasing serial engagement by increasing koff reduces Syk activation
In Fig. 2 we compare the predicted levels of β and γ ITAM phosphorylation and full Syk
activation induced by four different hypothetical ligands, two bivalent (circles) and two
trivalent (squares), that have the same single site forward rate constants k+2 = 2.0 × 10−11
cm2/s. (In the simulations we take the surface area of the cell A = 8 × 10−6 cm2 and the total
number of receptors per cell NT = 4 × 105 so that the receptor density RT = 5 × 1010 cm−2.
Therefore, at low ligand concentrations when most of the receptors are free so that R ≈ RT,
the rate at which a bound ligand with one site free cross-links a receptor is k+2R = 1.0 s−1.)
Each pair of bivalent and trivalent ligands have dissociation rate constants koff = 0.01 s−1
(solid lines and symbols) and 10 s−1 (dashed lines and open symbols). For the dimers,
increasing koff from 0.01 s−1 to 10 s−1 corresponds to increasing the rate of serial
engagement from r2 = 0.017 s−1 to 0.10 s−1 (Eq. 4) while for the trimer the increase is from
r3 = 0.027 s−1 to 0.20 s−1 (Eq. 5). In addition to increasing the rate of serial engagement,
increasing koff reduces the lifetime of the bond between a site on the ligand and a receptor
site and thus, increases the effects of kinetic proofreading [4]. As previously discussed [22],
to equalize the comparison, the levels of phosphorylation are plotted as a function of the
number of receptors in aggregates. Figure 2A shows the ligand concentrations needed to
achieve the same level of receptor aggregation for the different ligands. As koff is increased
while keeping k+2RT fixed, for both bivalent and trivalent ligands, a higher ligand
concentration is required to yield the same number of aggregated receptors, since the rate at
which the receptor cross-link is broken is enhanced, whereas the rate at which the cross-
links form remains unaltered. In Fig. 2D, we see that as the lifetime of a receptor in an
aggregate is decreased, i.e., koff is increased, full Syk activation is dramatically reduced for
both bivalent and trivalent ligands. Kinetic proofreading dominates any positive effects
serial engagement may have on Syk activation. This result is similar to that seen in
experiments using fast and slowly dissociating multivalent ligands that aggregate IgE on
RBL cells [37].
Figure 2B and Fig. 2C show that the proximal signaling events, β and γ ITAM
phosphorylation, compared with Syk phosphorylation, are effected less by the changes in the
ligand-receptor complex lifetime as expected from a kinetic proofreading model [4]. The
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reduction in Syk phosphorylation is pronounced because it is much further down the
signaling cascade than phosphorylation of the receptor γ-chain. A number of reversible steps
must occur to go from γ-chain phosphorylation to Syk phosphorylation. A Syk molecule
must first bind to a phosphorylated γ-chain before it is dephosphorylated. For
transphosphorylation to occur, a second Syk molecule must bind, which requires a second γ-
chain to be phosphorylated in the same aggregate. Finally, transphoshorylation among the
Syk molecules must occur before either of the Syk molecules dissociates.
Increasing serial engagement by increasing k+2 increases Syk activation
In Fig. 3 we compare the levels of β and γ ITAM phosphorylation and full Syk activation
induced by four different hypothetical ligands, two bivalent (circles) and two trivalent
(squares), that have the same dissociation rate constant koff = 0.1 s−1 and different surface
cross-linking constants. Each pair of bivalent and trivalent ligands have surface cross-
linking constants such that k+2RT = 0.1 s−1 (solid lines and open symbols) and 100 s−1
(dashed lines and closed symbols). As in Fig. 2, we compare ligands at different
concentrations that result in the same number of receptors being in aggregates at
equilibrium. Since koff is fixed, the lifetime of a receptor in an aggregate is the same for all
four ligands. As k+2RT is increased from 0.1 s−1 to 100 s−1, the rate of serial engagement for
the bivalent ligand increases from 0.067 s−1 to 0.20 s−1 (Eq.(4)), and for the trivalent ligand
from 0.13 s−1 to 0.30 s−1 (Eq.(5)). (These rates of serial engagement where calculated for
low ligand concentrations, when R ≈ RT and k+2R ≈ k+2RT.) We see that the simulations
predict that increasing the rate of serial engagement while holding koff fixed has a minor
effect on receptor phosphorylation (Figs. 3B and C), but a more pronounced effect on the
phosphorylation of Syk by Syk, i.e, on full Syk activation (3D).
Increasing the valence of a ligand increases Syk activation, partly as a result of increased
serial engagement
From Eq. (4) and Eq. (5) we can calculate the increase in the rate of serial engagement as a
result of increasing the valence of a ligand from two to three while keeping its rate constants
unchanged. The factor by which the rate of serial engagement increases, r3/r2, depends only
on the parameter k+2R, and monotonically decreases from 2 to 3/2 as k+2R increases from
zero to infinity. In Figure 4, as in 3, we compare the predicted full Syk activation from
simulations where the stimulating ligand is either bivalent (circles) or trivalent (squares), the
rate of serial engagement is varied by varying k+2, and for both ligands the lifetime of a
receptor bound to a ligand is the same, 10 s (koff = 0.10 s−1). The range over which the rate
of serial engagement varies in Fig. 4 corresponds to k+2R = 0.01 — 100 s−1. In Fig. 4A, the
two top curves and two bottom curves correspond to 1000 and a 100 receptors per cell in
aggregates. For the same rate of serial engagement and the same number of receptors in
aggregates, the model predicts that the trivalent ligand is more effective than the bivalent
ligand at activating Syk.
In Fig. 4B we re-plot the simulations for the upper two curves in Fig. 4A. To illustrate how
we can asses the contribution of serial engagement in enhancing Syk phosphorylation by
Syk when the valence is increased, we consider the point labeled 1 on the Syk activation
curve for the bivalent ligand in Fig. 4B. This point corresponds to the serial engagement rate
for a bivalent ligand with k+2R = 0.01 s−1 and koff = 0.10 s−1. When the valence is increased
from two to three with the rate constants unchanged, the rate of serial engagement for the
trimer increases above that of the dimer to the point on the trivalent ligand curve labeled 2.
We see that there would be an increase in Syk phosphorylation by Syk for a trivalent ligand
even if there was no increase in the rate of serial engagement. This is indicated by the
difference B-A on the y-axis and is a result of effects other than serial engagement. The
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increase in Syk activation that is attributable to the increase in serial engagement is indicated
by the difference C-B on the y-axis, which can be substantial.
Lyn is strongly regulated by Cbp and Csk [38, 39] on RBL cells and as a result, the amount
of Lyn available to the receptor is in short supply [33, 34]. Although Lyn regulation is not in
the model, the Lyn concentration is chosen so that Lyn is limiting with respect to availability
to the receptor. In the model, in the absence of ligand, less than five percent of the receptors
are associated with Lyn, which is consistent with the observations of Yamashita et al. [40].
Upon aggregation, large receptor aggregates are more likely to contain a Lyn than small
receptor aggregates, and once a Lyn is in an aggregate it can transphosphorylate all receptors
in its proximity. It is these effects that the model captures when the valence of the ligand is
increased from two to three and that account for the increase in Syk phosphorylation that is
not a result of serial engagement. We investigate this further by considering ligands that
cannot serial engage receptors.
Serial engagement is not necessary for Syk activation
Although the aggregation of FcεRI is an absolute requirement for mast cell signaling
mediated by FcεRI, serial engagement is not, as has been demonstrated using oligomers of
IgE [23]. As a test of our model [22], we have carried out simulations for bivalent and
trivalent oligomers of IgE, taking the dissociation rate constant koff = 0, which ensures that
there is no serial engagement. (Since the half-life for dissociation of an IgE-Fcε complex is
close to a day [41], this is an excellent approximation in simulating experiments that last a
few hours or less.) The predicted results for γ-phosphorylation and Syk activation for IgE
dimers and trimers at one hour are shown in Fig. 5A and 5B. These results are compared to
histamine release dose response curves for RBL-2H3 cells exposed to IgE oligomers for one
hour. Because of the slow forward rate constant for IgE binding to FcεRI [42], equilibrium
is achieved at one hour only for IgE concentrations greater than about 5 µg/ml. The
simulations indicate that to achieve measureable histamine release from RBL cells requires
the activation of substantial numbers of Syk molecules. For example, the simulations predict
that 10% histamine release with trivalent ligands, which is about 25% of maximal release,
occurs when approximately 10,000 Syk are fully activated.
Discussion
When surface densities of receptors are sufficiently high, multivalent ligands can bind to cell
surfaces and serial engage numerous receptors before dissociating, i.e., before all of the
ligand’s binding sites are simultaneously free.
Even with a valence as low as two, a ligand can engage multiple receptors from the time it
first attaches to the surface until the time it dissociates (see Table I). A single ligand binding
site may bind a receptor, dissociate from it, and repeat the cycle with a new receptor
multiple times before the ligand leaves the surface. Using a detailed mathematical model, we
have investigated the role of serial engagement of FcεRI in mast cell signaling. The model
was originally developed for oligomers of IgE binding to FcεRI on the surface of RBL cells
[22]. For multivalent ligands binding reversibly to IgE-FcεRI complexes, the model applies
when IgE acts as a monovalent receptor. We use the model for multivalent ligands at low
concentration, when the binding of two ligands to one IgE is negligible, and the
concentration of free receptors is high so that serial engagement is favored. The model
includes the binding and cross-linking reactions between a bivalent or trivalent ligand and an
IgE-FcεRI complex, the reactions among the subunits of FcεRI, Lyn, and Syk, and
phosphatases which are not explicitly included in the model but are assumed to be present in
the background and that rapidly dephosphorylate unprotected phosphotyrosines. Previously
[22], the concentrations of all the components of the model in RBL cells were determined.
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All the parameters of the model were either directly measured or estimated based on fits of
model predictions to experiment. The model was shown to be consistent with a variety of
experimental data in which RBL cells were exposed to covalently cross-linked dimers of IgE
including the kinetics of receptor subunit phosphorylation and Syk phosphorylation. The
model was also consistent with dephosphorylation experiments [30,31] where RBL cells,
sensitized with IgE, were first exposed to a multivalent ligand and then receptor aggregates
were broken up with the addition of excess monovalent hapten. It is well suited to
investigate the role of serial engagement in the early cell signaling events initiated when
RBL cells, sensitized with monoclonal IgE, are exposed to low concentrations of multivalent
ligand that can aggregate the IgE into small aggregates of size two or three.
A basic assumption of the model is that when a ligand is bound to more than one receptor
and a bond opens, the freed receptor diffuses away before the site on the ligand can rebind to
it. This is a reasonable assumption as long as receptors remain mobile on the cell surface.
On RBL cells, receptors in small aggregates remain mobile [21], but receptors in large
aggregates do not [19, 20]. When receptors are immobile we expect serial engagement to be
markedly reduced and have little effect on cell signaling. We have only considered the case
when receptors remain mobile on the RBL surface and results do not apply to large
aggregates where receptors are immobile. The expression we have derived for the rate of
serial engagement for a ligand of valence N, Eq. (3), holds only when receptors are mobile.
We considered three ways in which serial engagement could be increased: by increasing the
rate at which a ligand binding site dissociates from a receptor; by increasing the rate at
which a free site on a ligand that is bound to a receptor can cross-link a new receptor; and by
increasing the valence of the ligand. We took as our measure of signaling response the
predicted number of Syk per cell that were bound to phosphorylated γ-ITAMs and that were
phosphorylated on their activation loop tyrosines. In the model this phosphorylation arises
through Syk transphosphorylation and requires that at least two Syk molecules are present,
each bound to a different receptor in the aggregate, for the phosphorylation to occur. Model
simulations showed that increasing the rate of serial engagement by increasing the rate of
dissociation reduced the concentration of activated Syk (see Figure 2d). Increasing the rate
of dissociation of a ligand-receptor bond, decreases the lifetime of a receptor in an aggregate
and increases the effect of kinetic proofreading. The further down the signaling pathway an
event occurs, the more pronounced are the effects of kinetic proofreading on the event, as
can be seen by comparing the predicted γ-chain phosphorylation (Figure 2c) with the
predicted Syk phosphorylation (Figure 2d). Whatever positive effects serial engagement has
on signaling are outweighed by kinetic proofreading when the lifetime of the ligand-receptor
bond is decreased[4, 37].
Simulations predict that increasing the rate at which cross-linking occurs, while keeping the
lifetime of the bond between a ligand site and receptor constant so as not to enhance kinetic
proofreading, increases Syk activation. In Figure 4a, a single curve corresponds to a series of
bivalent or trivalent ligands with increasing rates of serial engagement achieved by
increasing cross-linking constants. The ligands have the same dissociation rate constants and
their concentrations have been chosen so that they aggregate the same number of receptors
on the cell surface, yet the faster the ligands are able to serial engage receptors, the more
Syk they are able to activate. This raises the question, why should serial engagement matter
if the lifetime of a receptor in an aggregate is the same and the number of receptors in
aggregates is as well? The explanation we favor is that serial engagement can partially
nullify the effects of kinetic proofreading by allowing receptors that have dissociated from
an aggregate to enter new aggregates before they fully return to their basal state. Previously
we estimated that when a receptor leaves an aggregate its unprotected phosphotyrosines are
dephosphorylated in less than a second, and any Syk or Lyn that are bound to
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phosphorylated ITAMS dissociate with half-lives of the order of 10−15 s [22]. Even within
an aggregate, phosphorylation and dephosphorylation is constantly occurring [23]. If a
receptor can enter into a new aggregate before all the modifications it has undergone have
been reversed, full activation of Syk will be more efficient. As depicted in Figure 6 for a
bivalent ligand, at low ligand concentration, a receptor that remains bound to a ligand when
an aggregate breaks up is much more likely to quickly enter into a new aggregate than a
receptor with its binding site free, provided the rate for cross-linking a new receptor is equal
to, or faster than the rate of dissociation of the ligand-receptor bond, i.e., k+2R ≥ koff, or
equivalently K2R ≥ 1. Even when this condition on the rate constants is met, serial
engagement can only partially reduce the effects of kinetic proofreading since free receptors
that leave an aggregate will most likely return to the basal state before they form new
aggregates.
The model also predicts that increasing the valence of a ligand from two to three, while
keeping the rate constants the same, increases Syk activation (Figure 4). The expressions we
have derived for the rates of serial engagement of dimers and trimers, Eq. (4) and Eq. (5),
show that increasing the valence while keeping all other quantities fixed increases the rate of
serial engagement. However, the predicted increase in Syk activation is not solely due to the
increase in serial engagement. Both experiment [32] and the model predictions (Figure 5)
indicate that trimeric oligomers of IgE are more effective than dimers at activating RBL
cells, even though these ligands cannot serial engage receptors. This is because Lyn is
limiting in RBL cells with most receptors not associated with a Lyn [40, 33, 34]. Large
aggregates are more likely than small aggregates to have a Lyn bound to a receptor in the
aggregate and initiate signaling. Further, the larger the aggregate, the higher is the number of
receptors that can be phosphorylated by a single Lyn. Serial engagement can enhance this
signaling. We have estimated the additional contribution to Syk activation that the increase
in serial engagement makes when a trivalent ligand is substituted for a bivalent ligand and
shown that it can be substantial (Figure 4b).
Ligand-induced receptor aggregation initiates a chemical cascade that involves chemical
reactions that build and use transient molecular scaffolds. Upon aggregation of FcεRI on
mast cells, the cytoplasmic domains of the receptor become sites for the coalescence of the
kinases Lyn and Syk, with Syk undergoing rapid phosphorylation. However, the structures
formed around the cytoplasmic domains of the receptor, as well as other scaffolding
proteins, are ephemeral with components going on and off rapidly. How successful this
construction will be depends on the lifetime of a receptor in an aggregate. If the lifetime is
too short, most of the chemical cascades that are initiated will not go to completion, and
signaling will be dampened or completely prevented. This is the idea behind kinetic
proofreading (reviewed in [5]), introduced in the context of cell signaling by McKeithan [4],
and kinetic proofreading has highlighted the role of the pMHC-TCR bond dissociation rate
constant in T-cell signaling. We have used a mathematical model of the initial steps in the
chemical cascade triggered by FcεRI aggregation on mast cells to investigate the role of
serial engagement in signaling, and shown that for a series of ligands with the same
dissociation rate constant, increasing the forward rate constant for cross-linking, or
increasing the ligand valence increases serial engagement and Syk activation. Serial
engagement is able to partially reverse the effects of kinetic proofreading and enhance mast
cell signaling.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix
We derive an expression for nN, the average number of receptors an N-valent ligand, that
initially has one site bound to a receptor, serial engages before it dissociates from the cell
surface. We consider a cell with monovalent receptors on its surface that is in equilibrium
with a homogeneous concentration of N-valent ligands. At equilibrium there is a distribution
of bound ligands, some with one site bound, some with two sites bound, up to some with N
sites bound. We consider an ensemble of N-valent ligands that at t=0 have one and only one
site bound to a receptor. We let Bi(t) be the fraction of these ligands that have i sites bound
at time t or equivalently, the probability that a ligand has i sites bound at time t when
initially it had one site bound. We keep tract of the number of receptors a ligand serial
engages by keeping track of how many receptors dissociate from a ligand until the ligand
leaves the cell surface. Since the rate at which a receptor dissociates from a ligand with i
sites bound is ikoff, the average number of receptors a ligand will serial engage from the time
it binds to the cell until the time it leaves the cell is:
(1)
Before solving the general problem, we illustrate our approach by finding the number of
receptors a bivalent ligand serial engages during its time on the cell surface.
The equilibrium concentration of free receptors is represented by R. For a bivalent ligand we
have the following set of ordinary differential equations:
(2)
(3)
The initial conditions are that B1=1 and B2=0.
The average number of receptors a bivalent ligand engages during its time on the cell
surface is
(4)
As is standard, we use Laplace transforms (LT), to transform the problem into solving a set
of algebraic equations, taking s to be the transform variable and B̅i(s) = LT[Bi (t)]. Note that
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(5)
This follows because the Laplace transform of  and
(6)
Taking Laplace transforms of both sides of Eq. (2) and Eq. (3) we have
We can take the limit before we solve the equations. Setting s = 0, k = k+2R/koff = K2R and
B1(0)=1,
Solving we have that B̅2 = k / (2koff)
(7)
For a ligand with valence N,
(8)
Bi can appear through dissociation of a receptor from any of i+1 receptor-occupied sites of
Bi+1, which correspond to a term (i+1)koff Bi+1; through engaging of a receptor by any of (N
−(i−1)) free sites of Bi−1, which corresponds to a term (N−i+1)k+2RBi−1. Bi can disappear
by losing a receptor from any of its i receptor-bound sites and by adding a receptor to any of
(N−i) free sites, which corresponds to subtraction of terms ikoffBi and (N−i)k+2RBi
respectively.
Putting k = k+2R/koff, τ = kofft, B0 = BN+1 = 0, and collecting terms,
(9)
(Note that B0 = BN+1 = 0 implies that the corresponding Laplace transforms B̅0 = B̅N+1 = 0.)
As before, taking Laplace transforms and setting the transform variable equal to zero, we
obtain
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First, we solve this system of equations for B̅1by summing all the equations:
The sum on the right hand side equals zero, so that B̅1 = 1. To find B̅2, we sum up all
equations except the first one:
Again, the sum on the right hand side equals zero so that
Similarly,
Following this approach, it is straightforward to show that
(10)
and therefore,
(11)
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Figure 1.
The multiple reactions that a ligand of valence five (N=5) can undergo from the time it first
binds a cell surface receptor until the last ligand-receptor bond breaks and the ligand leaves
the surface. R is the concentration of free receptors. In these reactions, k+2 is the single-site
rate constant for addition of a receptor to a ligand-receptor complex and koff is the
corresponding reverse rate constant. By taking all the forward and reverse rate constants to
be the same we have assumed that these rate constants are independent of the bound state of
the ligand.
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Figure 2.
Simulation of the effects of increasing the rate of serial engagement of bivalent and trivalent
ligand by increasing the ligand-receptor dissociation constant, koff. The four curves
correspond to k+2RT = 1.0 s−1 and bivalent (circles) and trivalent (squares) ligands with koff
= 0.01 s−1 (solid lines and symbols) and 10 s−1 (dashed lines and open symbols). The
additional parameters used in the simulations are given in Table 1 of Ref. [22]. The x-axis
indicates levels of FcεRI aggregation, given as the number of receptors per cell in
aggregates. One percent of the cell’s receptors in aggregates corresponds to 4 × 103
receptors. A. Free ligand concentrations corresponding to specified levels of receptor
aggregation. B., C., and D. are respectively the predicted number of receptors per cell with
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the β ITAM phosphorylated, the γ ITAM phosphorylated, and Syk bound to the
phosphorylated γ ITAM and transphosphorylated on its activation loop by another Syk.
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Figure 3.
Simulation of the effects of increasing the rate of serial engagement of bivalent and trivalent
ligand by increasing the rate of cross-linking, k+2R. The four curves correspond to koff = 0.1
s−1 and bivalent (circles) and trivalent (squares) ligands with k+2R = 0.1 s−1 (solid lines and
open symbols) and 100 s−1 (dashed lines and closed symbols). All other parameters are the
same as in Figure 2. The x-axis indicates levels of FcεRI aggregation, given as the number
of receptors per cell in aggregates. A. Free ligand concentrations corresponding to specified
levels of receptor aggregation. B., C., and D. are respectively the predicted number of
receptors per cell with the β ITAM phosphorylated, the γ ITAM phosphorylated, and Syk
bound to the γ ITAM and transphosphorylated by Syk on its activation loop.
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Figure 4.
Predicted number of activated Syk (Syk transphosphorylated by Syk) as a function of the
rate of serial engagement. A. The circles refer to bivalent ligand simulations and the squares
to trivalent ligand simulations. Open and solid symbols refer to 1000 and 100 receptors in
aggregates respectively. B. Replot of the bivalent and trivalent curves in (A) for 1000
receptors in aggregates. The symbol 1 corresponds to a dimer with k+2R = 0.01 s−1 and koff =
0.10 s−1. The symbol 2 corresponds to a trimer with the same rate constants. A=100, B=161
and C=290 fully activated Syk per cell. The net increase in activated Syk, (C-A) is 190 Syk
per cell, of which C-B=129 Syk per cell can be attributed to serial engagement.
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Figure 5.
Predicted γ and Syk phosphorylation, and measured RBL-2H3 cell degranulation, for
dimeric and trimer oligomers of IgE. In A. and B. the circles refer to IgE dimer simulations
and the squares to IgE trimer simulations. The rate constants characterizing the oligomers
are taken to be koff = 0 s−1k+1 = 8 × 104 M−1 s−1 and k+2 RT = 100 s−1. The simulations
correspond to exposure of the ligands to RBL-2H3 cells for one hour. C. Experimentally
determined degranulation of RBL-2H3 cells after one hour of exposure to either dimers or
trimers of IgE [32].
Nag et al. Page 21
J Immunol. Author manuscript; available in PMC 2011 May 26.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 6.
At low ligand concentration, when most receptors are unbound, a receptor-ligand complex
that dissociates from an aggregate (1), can rapidly enter a new aggregate (2), provided that
the rate of cross-linking is greater than the rate of dissociation of its ligand-receptor bond. If
this is not the case, the ligand-receptor complex will be rapidly converted to a free receptor,
reducing its chance of quickly finding a binding partner.
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